DEF: TAO Synergies Seeks Shareholder Approval for Major Dilutive Financing and Expanded Equity Plan to Fund AI Crypto Strategy

TAO Synergies Inc. is seeking stockholder approval for a significant dilutive financing transaction to fund a new AI cryptocurrency treasury strategy and to expand its equity incentive plan, with a special meeting scheduled for August 6, 2025.

Summary

• TAO Synergies Inc. (formerly Synaptogenix, Inc.) is holding a virtual special meeting on August 6, 2025, to vote on three key proposals.
• The primary proposal seeks stockholder authorization for the issuance of common stock underlying convertible preferred stock and warrants, which could exceed 20% of outstanding common stock, to comply with Nasdaq Listing Rules 5635(c) and 5635(d).
• This issuance is tied to a private placement offering on June 9, 2025, which generated gross proceeds of $5.5 million from the sale of 5,500 shares of Series D convertible preferred stock and warrants.
• The Series D Preferred Stock is initially convertible into up to 1,833,333 common shares at $3.00 per share, and the warrants allow purchase of up to 1,833,333 common shares at $3.00 per share.
• Additional warrants were issued: 1,200,000 common shares to consultant James Altucher and Z-List Media, Inc. (Consultant Warrants) with exercise prices ranging from $4.00 to $12.00, and 55,000 common shares to placement agent GP Nurmenkari Inc. (GPN Warrants) at $3.00 per share.
• The total potential issuance from these securities is 4,921,666 common shares, significantly exceeding the 1,756,682 common shares outstanding prior to the financing.
• The financing aims to raise additional funds for general corporate purposes, working capital, and an initial acquisition of $10 million of Bittensor TAO tokens for a new cryptocurrency treasury strategy.
• The second proposal is to amend the 2020 Equity Incentive Plan, increasing the shares available for awards by 2,000,000 (to a total of 2,675,000 shares) and renaming it to TAO Synergies Inc. 2020 Equity Incentive Plan.
• The third proposal seeks approval to adjourn the special meeting if necessary to solicit additional proxies for the other two proposals or to establish a quorum.

Sentiment

Score: 4

Explanation: While the company secured funding and is pursuing a new strategic direction, the significant potential dilution, the need for shareholder approval to avoid substantial cash payments, and the complex terms of the preferred stock and warrants introduce considerable risk and uncertainty for existing shareholders. The shift to AI crypto is speculative and unproven for the company.

Positives

• Secured $5.5 million in gross proceeds from the private placement offering.
• Launched a new differentiated cryptocurrency treasury strategy focused on Bittensor TAO, which is currently the leading AI token by market capitalization and adoption.
• Engaged James Altucher and Z-List Media, Inc. for crypto portfolio management, investor relations, strategic planning, and deal flow analysis, leveraging external expertise for the new strategy.
• The proposed increase in shares for the Equity Incentive Plan aims to attract, retain, and motivate key personnel, which is vital for future performance.

Negatives

• The potential issuance of 4,921,666 common shares from the Series D Preferred Stock, Warrants, Consultant Warrants, and GPN Warrants represents significant dilution to current stockholders, as it is substantially more than the 1,756,682 common shares outstanding prior to the financing.
• The Series D Preferred Stock includes anti-dilution provisions and requires redemption in cash at 107% of the installment amount, potentially increasing future cash outflows.
• Failure to obtain stockholder approval for the Issuance Proposal would prevent the company from issuing sufficient shares, potentially requiring substantial cash payments to holders of the Securities, which the company does not anticipate having sufficient funds to make.
• The Series D Preferred Stock accrues dividends at 5% per annum, compounded quarterly, payable in cash, increasing to 15% upon a Triggering Event.
• The Warrants and GPN Warrants are subject to price-based adjustment on a full ratchet basis, meaning their exercise price can be reduced if the company issues common stock at a lower price, leading to further dilution.

Risks

• Significant dilution of current stockholders' percentage ownership due to the potential issuance of up to 4,921,666 common shares from the Series D Preferred Stock, Warrants, Consultant Warrants, and GPN Warrants.
• Risk of delisting from Nasdaq if stockholder approval for the issuance of more than 20% of outstanding common stock is not obtained.
• Inability to issue sufficient shares upon conversion or exercise of the Securities if the Issuance Proposal is not approved, which would require substantial cash payments that the company does not anticipate having sufficient funds for.
• Financial strain from required cash redemptions of Series D Preferred Stock at 107% of the installment amount, commencing September 30, 2025.
• Increased dividend payments on Series D Preferred Stock (5% per annum, increasing to 15% upon a Triggering Event) could strain cash flow.
• Potential decline in the market price of common stock due to the issuance or resale of the large number of new shares.
• The anti-dilution features of the Series D Preferred Stock, Warrants, and GPN Warrants could further reduce conversion/exercise prices, leading to even greater dilution.
• The company generally has no control over whether holders of Series D Preferred Stock convert or warrant holders exercise, making the exact magnitude of dilution uncertain.
• The increased number of issued shares could have an incidental anti-takeover effect, making certain mergers, tender offers, or change of control transactions more difficult.

Future Outlook

The company intends to acquire $10 million of Bittensor TAO tokens initially as soon as practicable, as part of its new differentiated cryptocurrency treasury strategy. Management believes the proposed increase in shares for the equity incentive plan will provide sufficient shares for future awards for two additional years, enabling the company to attract, retain, and motivate key personnel.

Management Comments

• "We hope you will be able to attend the special meeting. Whether you plan to attend the special meeting or not, it is important that you cast your vote either in person or by proxy."
• "We believe the issuance or delivery of shares of Common Stock underlying the Consultant Warrants to Mr. Altucher should not be treated as equity compensation within the meaning of Rule 5635(c). However, it is possible Nasdaq may deem all or a portion of any arrangement as compensatory in nature."
• "We believe that the Offering, which yielded gross proceeds of $5.5 million, was necessary in light of the Company’s cash and funding requirements at the time and the launch of the differentiated cryptocurrency treasury strategy."
• "We also believe that the anti-dilution protections contained in the Series D Preferred Stock and Warrants were reasonable in light of market conditions and the size and type of the Offering, and that we would not have been able to complete the sale of the Series D Preferred Stock and Warrants unless such anti-dilution provisions were offered."
• "Our Board, the Compensation Committee and management believe that the effective use of stock-based long-term incentive compensation is vital to our ability to achieve strong performance in the future."
• "Our future success depends, in large part, upon our ability to maintain a competitive position in attracting, retaining and motivating key personnel."
• "Our Board currently believes that if the amendment to the Plan is approved by stockholders, the 2,675,000 shares available for issuance under the Plan will result in an adequate number of shares of Common Stock being available for future awards under the Plan for two additional years following the current year."

Industry Context

TAO Synergies Inc.'s pivot to a cryptocurrency treasury strategy focused on Bittensor TAO, a pure-play artificial intelligence (AI) crypto coin, aligns with the growing interest and investment in AI-related technologies and the broader trend of companies exploring digital assets for treasury management. This move positions the company to potentially capitalize on the burgeoning AI and blockchain sectors, differentiating itself from traditional biotech or pharmaceutical companies (given its former name Synaptogenix, Inc.). The engagement of James Altucher for crypto portfolio management further emphasizes this strategic shift into a specialized and rapidly evolving market.

Corporate Governance

Stakeholder Impact

• Shareholders: Face significant potential dilution of their percentage ownership and voting power due to the large number of shares issuable from the financing. The market price of common stock could decline. However, approval of the proposals is crucial to avoid substantial cash payments the company cannot afford, which could lead to financial distress or delisting.
• Employees/Consultants/Directors: Benefit from the expanded 2020 Equity Incentive Plan, which aims to provide long-term, equity-based incentives, aiding in attraction, retention, and motivation. The consultant, James Altucher, received substantial warrants for his services.
• Investors (in the Offering): Benefit from the Series D Preferred Stock's conversion features, anti-dilution provisions, 5% (or 15% upon Triggering Event) cash dividends, and 107% redemption premium. They also have the right to participate in future securities offerings.
• Placement Agent (GP Nurmenkari Inc.): Receives a 7.0% cash fee on gross proceeds and warrants for 3.0% of the initial Series D convertible shares.

Next Steps

• Hold a virtual special meeting of stockholders on August 6, 2025, to vote on the Issuance Proposal, Plan Amendment Proposal, and Adjournment Proposal.
• Acquire $10 million of Bittensor TAO tokens initially, as soon as practicable, for the new cryptocurrency treasury strategy.
• File a resale registration statement with the SEC for the Consultant Warrant Shares on or prior to 90 days from their issue date.
• File a resale registration statement with the SEC for the Unregistered Conversion Shares and Warrant Shares promptly following the closing of the Offering, but no later than 30 calendar days after the effective date of the Registration Rights Agreement, and have it declared effective by the Effectiveness Date.
• Redeem Series D Preferred Stock in equal quarterly installments, commencing on September 30, 2025.
• Publish preliminary or final voting results in a Current Report on Form 8-K within four business days of the special meeting.

Key Dates

Recommendation

Keywords

TAO Synergies, Synaptogenix, SEC Filing, Proxy Statement, DEF 14A, Stockholder Meeting, Equity Incentive Plan, Share Dilution, Convertible Preferred Stock, Warrants, Private Placement, Nasdaq Listing Rules, Corporate Governance, AI Crypto, Bittensor TAO, Treasury Strategy, Capital Raise, Investor Relations, James Altucher